XBiotech (NASDAQ:XBIT) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Free Report) in a research report report published on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. XBiotech Price Performance XBIT opened at $4.00 on Friday. The stock has a market cap of $121.75 million, a P/E ratio of -3.36 and […]
More Stories
Rhythm Pharmaceuticals (NASDAQ:RYTM) Sees Large Volume Increase – What’s Next?
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 507,031 shares changed hands...
IPG Photonics (NASDAQ:IPGP) Trading 3.8% Higher – Time to Buy?
IPG Photonics Co. (NASDAQ:IPGP – Get Free Report) shares rose 3.8% during trading on Monday . The stock traded as...
Sweetgreen (NYSE:SG) Stock Price Down 5.8% – Should You Sell?
Sweetgreen, Inc. (NYSE:SG – Get Free Report)’s stock price was down 5.8% on Monday . The company traded as low...
Coinbase Global (NASDAQ:COIN) Shares Down 4.4% – What’s Next?
Coinbase Global, Inc. (NASDAQ:COIN)’s stock price was down 4.4% during mid-day trading on Monday . The company traded as low...
Financial Contrast: Advent Technologies (NASDAQ:ADN) versus Gauzy (NASDAQ:GAUZ)
Gauzy (NASDAQ:GAUZ – Get Free Report) and Advent Technologies (NASDAQ:ADN – Get Free Report) are both small-cap computer and technology...
Steelcase (NYSE:SCS) Hits New 12-Month Low – Time to Sell?
Steelcase Inc. (NYSE:SCS – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday ....